Get the Stockscreener App
0.4851
18.77%
-0.1121
After Hours:
.48
-0.0051
-1.05%
Liminatus Pharma Inc stock is traded at $0.4851, with a volume of 6.09M.
It is down -18.77% in the last 24 hours and down -37.01% over the past month.
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
See More
Previous Close:
$0.5972
Open:
$0.64
24h Volume:
6.09M
Relative Volume:
0.96
Market Cap:
$13.13M
Revenue:
-
Net Income/Loss:
$-1.40M
P/E Ratio:
-2.339
EPS:
-0.2074
Net Cash Flow:
$-10.49M
1W Performance:
-76.34%
1M Performance:
-37.01%
6M Performance:
-88.85%
1Y Performance:
+0.00%
1-Day Range:
$0.475
$0.6699
1-Week Range:
$0.475
$2.83
52-Week Range:
$0.475
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Name
Liminatus Pharma Inc
Sector
Industry
Phone
213-273-5453
Address
6 CENTERPOINTE DR., LA PALMA
Compare LIMN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
0.4851 | 16.16M | 0 | -1.40M | -10.49M | -0.2074 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Liminatus Pharma Inc Stock (LIMN) Latest News
LIMN Liminatus Pharma (NASDAQ) pre-market +15% Feb 12 2026: earnings preview - Meyka
Why Liminatus Pharma Inc. Equity Warrant stock attracts global investorsWeekly Gains Summary & Safe Entry Momentum Stock Tips - mfd.ru
Highs Report: Is Liminatus Pharma Inc Equity Warrant stock showing strong momentumJuly 2025 Fed Impact & Community Trade Idea Sharing Platform - baoquankhu1.vn
Liminatus Pharma Settles Litigation Through Equity Issuance - TipRanks
Liminatus Pharma enters settlement agreement with Clear Street LLC - marketscreener.com
Liminatus Pharma Enters Settlement Agreement With Clear Street LLC - TradingView
LIMN down 26.83% intraday: Liminatus Pharma (NASDAQ) 09 Feb 2026 earnings ahead - Meyka
Bond Watch: Will Liminatus Pharma Inc benefit from current market trendsWeekly Trend Report & Detailed Earnings Play Strategies - baoquankhu1.vn
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
3 Penny Stocks to Watch Now, 2/5/26 - TipRanks
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.34% - Investing.com UK
United States shares lower at close of trade; Dow Jones Industrial Average down 0.34% By Investing.com - Investing.com India
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.34% - Investing.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Top movers analysis one hour before the close of the markets on 2026-02-03: top gainers and losers in today's session. - ChartMill
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
BC-Most Active Stocks - Yahoo Finance
NXP stock slides 5% premarket after outlook; investors brace for the earnings call - TechStock²
Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares - TechStock²
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Why Teradyne Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket - Benzinga
Valuation Update: Is Riverview Bancorp Inc a turnaround story2025 Historical Comparison & AI Forecast Swing Trade Picks - baoquankhu1.vn
Take Profit: Is Booking Holdings Inc a potential multi baggerJuly 2025 Snapshot & Long-Term Capital Growth Ideas - baoquankhu1.vn
Gains Report: Will Quanex Building Products Corporation benefit from sector rotation2025 Key Highlights & High Conviction Trade Alerts - baoquankhu1.vn
Cardinal Health, Inc. $CAH Shares Sold by Envestnet Portfolio Solutions Inc. - Defense World
What is Liminatus Pharma Inc. Equity Warrant’s market position2025 Price Action Summary & Long-Term Capital Growth Ideas - mfd.ru
Institution Moves: Is now the right time to enter Liminatus Pharma Inc Equity WarrantMarket Trend Summary & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Nasdaq Moves: What is the earnings history of ESGL Holdings Limited Equity Warrant2025 Breakouts & Breakdowns & Stepwise Trade Signal Implementation - baoquankhu1.vn
Market Fear: Is RFAIU exposed to currency risksJuly 2025 EndofMonth & Breakout Confirmation Trade Signals - baoquankhu1.vn
Valuation Update: What are the future prospects of Liminatus Pharma Inc Equity Warrant2025 Biggest Moves & Weekly Return Optimization Plans - baoquankhu1.vn
Signal Recap: What are the risks of holding Cyclacel Pharmaceuticals IncWeekly Investment Summary & Daily Momentum Trading Reports - baoquankhu1.vn
Liminatus Pharma Faces Nasdaq Bid Price Compliance Challenge - TipRanks
Liminatus Pharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Shorts Report: Is TBMC stock trending bullishQuarterly Trade Review & Weekly Top Stock Performers List - baoquankhu1.vn
Market Leaders: Whats next for Channel Therapeutics Corporation stock2025 Stock Rankings & Daily Stock Trend Reports - baoquankhu1.vn
Trading Action: Will Liminatus Pharma Inc outperform its industry peersWeekly Investment Report & Capital Efficiency Focused Strategies - baoquankhu1.vn
New Highs: Can Liminatus Pharma Inc sustain its profitabilityWeekly Profit Recap & AI Driven Stock Movement Reports - baoquankhu1.vn
Bearish Setup: Is Embecta Corp forming a double bottomMarket Performance Report & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Aug Momentum: Is A19QHVs growth already priced inJuly 2025 Macro Moves & Verified Swing Trading Watchlist - baoquankhu1.vn
Quarterly Earnings: Is Liminatus Pharma Inc stock risky to hold nowJuly 2025 Retail & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Bull Run: Can Liminatus Pharma Inc sustain its profitabilityJuly 2025 Action & Verified Technical Trade Signals - baoquankhu1.vn
Trading Action: Is UONEK stock a value trapMarket Performance Summary & Consistent Profit Alerts - baoquankhu1.vn
Gains Recap: Is Citigroup Capital XVI Preferred Security stock undervalued right nowInsider Buying & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Momentum Shift: How liquid is Liminatus Pharma Inc stockTrade Analysis Report & Real-Time Market Sentiment Alerts - baoquankhu1.vn
FOMO Trade: How is Roadzen Inc managing supply chain issuesMarket Risk Report & Safe Capital Growth Plans - baoquankhu1.vn
Will Liminatus Pharma Inc stock attract more institutional investorsWall Street Watch & Safe Capital Allocation Plans - Bộ Nội Vụ
Support Test: Will Liminatus Pharma Inc stock attract more institutional investors - Bộ Nội Vụ
Pullback Watch: Why is DATSW stock going downJuly 2025 Rallies & Low Risk Growth Stock Ideas - baoquankhu1.vn
Liminatus Pharma Inc Stock (LIMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):